Intra-gastric balloon therapy and weight reduction

Area of Science:

• Bariatric Surgery
• Obesity Management
• Gastroenterology

Background:

• Morbid obesity presents significant health challenges.
• Pre-operative weight loss can improve surgical safety and outcomes.
• Intra-gastric balloon therapy (IBT) is a potential intervention for weight reduction.

Purpose of the Study:

• To evaluate the effectiveness of intra-gastric balloon therapy (IBT) for weight reduction in morbidly obese patients.
• To assess changes in weight and body mass index (BMI) following IBT.

Main Methods:

• Prospective data collection from 50 consecutive morbidly obese patients.
• Standardized insertion and removal of intra-gastric balloons by a single operator.
• Balloons filled with 500-600 ml of methylene blue-stained saline.
• Management of post-insertion symptoms and data analysis from hospital records.

Main Results:

• The study cohort was 70% female, with a mean pre-IBT weight of 149.9 kg and BMI of 52.8 kg/m2.
• At six months, mean weight decreased to 133.5 kg and BMI to 47 kg/m2, representing a 22% excess weight loss.
• Significant weight and BMI reduction observed, with females showing a slightly higher percentage of excess weight loss (25% vs. 17%).

Conclusions:

• Intra-gastric balloon therapy (IBT) is an effective method for achieving significant weight loss in morbidly obese individuals.
• The average excess weight loss of 22% suggests IBT's utility as a pre-operative intervention.
• Further research is needed to quantify the specific benefits of pre-operative weight loss facilitated by IBT on surgical outcomes.